5470720 HIV antibody assays comprising p24-gp41 chimeric antigens

PATENT ABSTRACTS

233

5470720

5470759

HIV ANTIBODY ASSAYS COMPRISING P24-GP41 CHIMERIC ANTIGENS

ANTI-GLYCATED HEMOGLOBIN MONOCLONAL ANTIBODY AND METHOD FOR MEASURING GLYCATED HEMOGLOBIN

Helting Torsten B; Drevin Hakan; Nunn Michael F La Jolla, CA, UNITED STATES assigned to Pharmacia Genetic Engineering Inc The present invention relates to a DNA segment encoding a recombinant HIV p24 protein or HIV p24-gp41 fusion protein and a recombinant DNA (rDNA) molecule capable of expressing either protein. Cells transformed with the rDNA, methods for producing the fusion protein and diagnostic methods and systems using the fusion protein are also described.

5470734 RECOMBINANT HERPES VIRUS OF TURKEYS AND LIVE VECTOR VACCINES DERIVED THEREOF Sondermeijer Paulus J A; Claessens Johannes A J; Mockett Albert P A Boxmeer, NETHERLANDS assigned to Akzo Nobel NV The present invention is concerned with a recombinant Herpesvirus of Turkeys (HVT), containing a heterologous gene incorporated into an insertion region of the genome of HVT. The invention also relates to a vector vaccine comprising such a recombinant HVT which expresses a heterologous antigenic polypeptide and induces an adequate immune response on infection of an appropriate host animal.

Sugiyama Masarn; Uchida Yoshiak; Kurano Yoshihir; Tanaka Aiko; Tanimoto Tetsuj Tokyo, JAPAN assigned to Fujirebio Inc A method for measuring glycated hemoglobin is disclosed, which comprises contacting a with an sample anti-hemoglobin antibody being bound to a solid phase, adding thereto an anti-glycated hemoglobin antibody, and anti-glycated then measuring the hemoglobin antibody bound to the solid phase via glycated hemoglobin and the anti-hemoglobin antibody. A method for measuring glycated hemoglobin is further disclosed, which comprises mixing a sample with particles on which an anti-glycated hemoglobin antibody is bound to cause immunoagglutination reaction. A method for measuring glycated hemoglobin is furthermore disclosed, which comprises mixing a sample with a solution containing a monoclonal antibody specific for glycated hemoglobin, and then measuring the change in the turbidity of the resulting mixture. A method is disclosed measuring glycated for hemoglobin which comprises mixing a sample with unsensitized latex particles and an anti-glycated hemoglobin antibody, to cause immunoagglutination reaction. There is disclosed a method for measuring glycated hemoglobin which comprises mixing a sample with unsensitized latex particles and particles on which an anti-glycated hemoglobin antibody is bound, to cause immunoagglutination reaction. Still furthermore, an anti-glycated hemoglobin monoclonal antibody having a high specificity for human glycated